About the journal
Oncology and Therapy is an open-access journal published by Adis, Springer Healthcare in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 5,950 EUR. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Adis, Springer Healthcare
- ISSN
- 2366-1070 · 2366-1089
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 5,950 EUR
- Articles in DOAJ
- 274
- Declared review time
- 6 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.springer.com/journal/40487
Index listings
- DOAJ · 2017-08-18
- Indexing
- DOAJ
- APC
- 5,950 EUR
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
274
Most recent article
3 months ago
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
411
Last recorded publication year
2026
h-index
33
i10-index
105
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2017-08-18
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 69%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101677510
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
- HER2/EGFR in Cancer Research
- Cancer survivorship and care
- HER2/EGFR in Cancer Research
Show all subjects (50)
- Lung Cancer Research Studies
- Multiple Myeloma Research and Treatments
- Advanced Breast Cancer Therapies
- Multiple Myeloma Research and Treatments
- Lung Cancer Research Studies
- Advanced Breast Cancer Therapies
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- CAR-T cell therapy research
- CAR-T cell therapy research
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Lung Cancer Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Breast Cancer Treatment Studies
- Acute Myeloid Leukemia Research
- Lung Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Bladder and Urothelial Cancer Treatments
- Prostate Cancer Treatment and Research
- Bladder and Urothelial Cancer Treatments
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- PARP inhibition in cancer therapy
- PARP inhibition in cancer therapy
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- Prostate Cancer Diagnosis and Treatment
- Colorectal Cancer Treatments and Studies
- Prostate Cancer Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Cutaneous Melanoma Detection and Management
- Cutaneous Melanoma Detection and Management
- Renal cell carcinoma treatment
- Chronic Lymphocytic Leukemia Research
- Renal cell carcinoma treatment
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Head and Neck Cancer Studies
- Health Systems, Economic Evaluations, Quality of Life
Keywords (DOAJ)
- cancer
- cancer-related conditions
- solid tumours
- haematologic malignancies
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ